HUT57590A - Process for producing liposome compositions comprisings antiandrogenic active ingredient - Google Patents

Process for producing liposome compositions comprisings antiandrogenic active ingredient

Info

Publication number
HUT57590A
HUT57590A HU907959A HU795990A HUT57590A HU T57590 A HUT57590 A HU T57590A HU 907959 A HU907959 A HU 907959A HU 795990 A HU795990 A HU 795990A HU T57590 A HUT57590 A HU T57590A
Authority
HU
Hungary
Prior art keywords
comprisings
active ingredient
liposome compositions
producing liposome
antiandrogenic
Prior art date
Application number
HU907959A
Other languages
English (en)
Other versions
HU907959D0 (en
HU215127B (hu
Inventor
Georg Roessling
Andreas Sachse
Jutta Riedl
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of HU907959D0 publication Critical patent/HU907959D0/hu
Publication of HUT57590A publication Critical patent/HUT57590A/hu
Publication of HU215127B publication Critical patent/HU215127B/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
HU907959A 1989-10-27 1990-10-10 Eljárás antiandrogén hatású, helyi alkalmazásra szolgáló, liposzómákat tartalmazó gyógyszerkészítmények előállítására HU215127B (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3936328A DE3936328A1 (de) 1989-10-27 1989-10-27 Pharmazeutische praeparate

Publications (3)

Publication Number Publication Date
HU907959D0 HU907959D0 (en) 1991-11-28
HUT57590A true HUT57590A (en) 1991-12-30
HU215127B HU215127B (hu) 1998-09-28

Family

ID=6392630

Family Applications (1)

Application Number Title Priority Date Filing Date
HU907959A HU215127B (hu) 1989-10-27 1990-10-10 Eljárás antiandrogén hatású, helyi alkalmazásra szolgáló, liposzómákat tartalmazó gyógyszerkészítmények előállítására

Country Status (15)

Country Link
US (1) US5723146A (hu)
EP (1) EP0451237B1 (hu)
JP (1) JP3011762B2 (hu)
AT (1) ATE103804T1 (hu)
AU (1) AU6553790A (hu)
CA (1) CA2028629C (hu)
DE (2) DE3936328A1 (hu)
DK (1) DK0451237T3 (hu)
FI (1) FI913100A0 (hu)
GR (1) GR900100772A (hu)
HU (1) HU215127B (hu)
IE (1) IE903859A1 (hu)
NO (1) NO912435L (hu)
PT (1) PT95697B (hu)
WO (1) WO1991006284A1 (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733776B1 (en) * 1992-04-02 2004-05-11 Anticancer, Inc. Method for promoting hair growth
US7556825B2 (en) * 1993-04-02 2009-07-07 Anticancer, Inc. Method for promoting hair growth
US6844326B2 (en) * 1995-06-07 2005-01-18 Anticancer, Inc. Treatment of alopecia
DE19916384A1 (de) * 1999-03-31 2000-10-05 Schering Ag Cyproteronacetat, Chlormadinonacetat oder 17alpha-Propylmesterolon enthaltende, bioerosive Mikropartikeln, Verfahren zu deren Herstellung, therapeutische Verwendung dieser in topischen Arzneiformen
JP3466516B2 (ja) 1999-09-07 2003-11-10 科学技術振興事業団 安定保存可能な酸素輸液剤
EP1316317A1 (fr) * 2001-11-30 2003-06-04 University of Liege Associations hydrosolubles à base de cyprotérone et/ou d'un ester de celle-ci, leurs préparations et leurs utilisations
US20030219465A1 (en) * 2002-05-23 2003-11-27 Suresh Kumar Gidwani Composition for delivery of dithranol
EP1643971A2 (en) * 2003-05-22 2006-04-12 Neopharm, Inc. Liposomal formulations comprising a combination of two or more active agents
US20050095283A1 (en) * 2003-09-16 2005-05-05 Aphios Corporation Compositions and methods for topically treating diseases
EP1784164A4 (en) * 2004-09-03 2008-07-09 Piedmont Pharmaceuticals Llc PROCESS FOR TRANSMEMBRANE TREATMENT AND PREVENTION OF OTITIS MEDIA
EA200800950A1 (ru) * 2005-09-26 2008-08-29 ПЬЕДМОН ФАРМАСЬЮТИКАЛЗ ЭлЭлСи Способы лечения и профилактики среднего отита с применением неионных поверхностно-активных веществ для облегчения трансмембранного введения лекарственного средства в среднее ухо
AU2006295236A1 (en) * 2005-09-26 2007-04-05 Piedmont Pharmaceuticals Llc Methods for treatment and prevention of otitis media using chemical penetration enhancers to facilitate transmembrane drug delivery into the middle ear
DE102006062120A1 (de) 2006-12-22 2008-06-26 Grünenthal GmbH Pharmazeutische Zusammensetzung zur Aknebehandlung
WO2008149601A1 (ja) * 2007-05-29 2008-12-11 Pola Chemical Industries Inc. 皮膚外用剤に有用なベシクル及び該ベシクルを含有する皮膚外用剤
EP2381946A4 (en) * 2008-10-10 2012-08-08 Teva Womens Health Inc METHOD FOR THE TREATMENT OF VASOMOTOR SYMPTOMS IN CASE RATED PROSTATE RAY PATIENTS WITH LOW-DOSED CYPROTERONE ACETATE
ITMI20110644A1 (it) * 2011-04-14 2012-10-15 Giuliani Spa Sistema per il rilascio prolungato di agenti cosmetici

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3728364A (en) * 1971-07-27 1973-04-17 Syntex Corp Preparation of 17alpha-propadienyl steroids
GB1570524A (en) * 1976-03-11 1980-07-02 Unilever Ltd Cosmetic
IL64397A0 (en) * 1981-01-07 1982-02-28 Weder Hans G Process for the preparation of liposomal medicaments
US4396615A (en) * 1981-06-24 1983-08-02 Duke University Method of treating androgen-related disorders
DE3279999D1 (en) * 1981-09-30 1989-11-30 Nat Res Dev Compositions comprising encapsulated particles
DE3416978A1 (de) * 1983-05-12 1984-12-06 Stauffer Chemical Co., Westport, Conn. Durch liposom vermittelte transformation eukaryotischer zellen
EP0240630A3 (en) * 1986-04-10 1989-01-25 University Of Miami Treatment of skin of over androgenicity using compositions containing pregnenolone
AU4805085A (en) * 1984-09-05 1986-03-24 Schering Aktiengesellschaft Mittel zur behandlung von androgenisierungserscheinungen und verwendung von antiandrogenen zur herstellung des mittels
IT1199625B (it) * 1985-01-08 1988-12-30 Finchimica Srl Uso terapeutico del ciproterone acetato
FR2619505B1 (fr) * 1987-08-20 1990-08-31 Dior Christian Parfums Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant de la pregnenolone ou un ester de pregnenolone, et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite regeneratrice ou revitalisante, l'incorporant
DE3738620A1 (de) * 1987-11-13 1989-05-24 Luderschmidt Christoph Verwendung von ethisterone zur topischen behandlung von akne oder androgenetischer alopezie
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs

Also Published As

Publication number Publication date
US5723146A (en) 1998-03-03
DE3936328A1 (de) 1991-05-02
HU907959D0 (en) 1991-11-28
HU215127B (hu) 1998-09-28
NO912435D0 (no) 1991-06-21
AU6553790A (en) 1991-05-02
WO1991006284A1 (de) 1991-05-16
CA2028629C (en) 2000-12-19
GR900100772A (el) 1992-03-20
CA2028629A1 (en) 1991-04-28
FI913100A0 (fi) 1991-06-25
ATE103804T1 (de) 1994-04-15
EP0451237B1 (de) 1994-04-06
JPH04503676A (ja) 1992-07-02
PT95697B (pt) 1997-09-30
DE59005281D1 (de) 1994-05-11
PT95697A (pt) 1991-09-13
NO912435L (no) 1991-06-21
EP0451237A1 (de) 1991-10-16
IE903859A1 (en) 1991-05-08
JP3011762B2 (ja) 2000-02-21
DK0451237T3 (da) 1994-07-18

Similar Documents

Publication Publication Date Title
HUT57590A (en) Process for producing liposome compositions comprisings antiandrogenic active ingredient
KR880005921A (ko) 의약용 소입자 에어로졸 리포좀 및 의약용 리포좀-약제 조합물
HUT64065A (en) Process for producing quinolone- and naphthyridonecarboxylic acid derivatives and pharmaceutical compositions comprising same as active ingredient
HUT55220A (en) Process for producing pharmaceutical composition suitable for systemic administration through the skin and comprising deprenyl as active ingredient
HUT47131A (en) Process for producing steroid-5alpha-reductase inhibitors and pharmaceutical compositions comprising them as active ingredient
HUT51254A (en) Process for producing amino acid derivatives and pharmaceutical compositions comprising same as active ingredient
HUT63163A (en) Process for producing anxiety relieving bis-azabicyclo compounds and pharmaceutical compositions comprising same as active ingredient
IL122486A (en) Process for making liposome preparation
HUT49625A (en) Process for producing macrolid compounds and pharmaceutical compositions comprising such active ingredient
HUT48609A (en) Process for producing kumaran derivatives and pharmaceutical compositions comprising same as active ingredient
EP0137543A3 (en) Pharmaceutical composition for the therapy of peripheral arteriopathies
HUT63577A (en) Process for producing pharmaceutical compositions suitable for intranasal treatment and sprayer for administering such compositions
HUT49598A (en) Process for producing chromone derivatives and pharmaceutical compositions comprising same as active ingredient
HUT49370A (en) Process for producing polypeptides and pharmaceutical compositions comprising same as active ingredient
HUT46660A (en) Process for producing 3-alkoxy-2-amino-propyl-amines and pharmaceutical compositions comprising the same as active ingredient
HUT47233A (en) Process for producing pharmaceutical comprising phenol derivatives as active ingredient and for producing the active ingredients
HUT44764A (en) Process for producing new sulfonamidoethyl derivatives and pharmaceutical preparations comprising them as active substance
GR3020575T3 (en) New 2-amino-5-cyano-1,4-dihydropyridines, process for their preparation and use in pharmaceutical compositions
HUT48232A (en) Process for producing new biphenyl derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HUT63151A (en) Process for producing new benzimidazole-2-sulfonamide and imidazopyuridine-2-sylfonamide derivatives, as well as pharmaceutical compositions comprising same as active ingredient
HUT44770A (en) Process for producing 6-phenoxymethyl-4-hydroxy-tetrahydropyran-2-one derivatives and pharmaceutical preparations comprising them as active substance
ES2006121A6 (es) Procedimiento para la preparacion de una composicion farmaceutica destinada al tratamiento de enfermedades cutaneas.
IE870577L (en) Topical amide preparation
IT1184729B (it) Prodotti farmaceutico cosmetico,in particolare per la cura di acne e seborrea
PL302010A1 (en) Novel pharmacologically active compounds, method of obtaining them, pharmaceutical agents containing such compounds, cosmetic preparation and novel intermediate compounds

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee